OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Determination of the Potential Clinical Benefits of Small Molecule Factor XIa Inhibitors in Arterial Thrombosis
Surasak Wichaiyo, Warisara Parichatikanond, Satsawat Visansirikul, et al.
ACS Pharmacology & Translational Science (2023) Vol. 6, Iss. 7, pp. 970-981
Open Access | Times Cited: 7
Surasak Wichaiyo, Warisara Parichatikanond, Satsawat Visansirikul, et al.
ACS Pharmacology & Translational Science (2023) Vol. 6, Iss. 7, pp. 970-981
Open Access | Times Cited: 7
Showing 7 citing articles:
Factor XI Inhibitors: A New Horizon in Anticoagulation Therapy
J Presume, Jorge Ferreira, Regina Ribeiras
Cardiology and Therapy (2024) Vol. 13, Iss. 1, pp. 1-16
Open Access | Times Cited: 9
J Presume, Jorge Ferreira, Regina Ribeiras
Cardiology and Therapy (2024) Vol. 13, Iss. 1, pp. 1-16
Open Access | Times Cited: 9
Emerging Targets, Novel Directions, and Innovative Approaches in Thrombosis Therapy
Weiyue Zhang, Baoqing Pei, Yifan Zhou, et al.
Aging and Disease (2025)
Open Access
Weiyue Zhang, Baoqing Pei, Yifan Zhou, et al.
Aging and Disease (2025)
Open Access
Distinct pleiotropic effects of direct oral anticoagulants on cultured endothelial cells: a comprehensive review
Natalia Atzemian, Dimitra Kareli, Georgia Ragia, et al.
Frontiers in Pharmacology (2023) Vol. 14
Open Access | Times Cited: 9
Natalia Atzemian, Dimitra Kareli, Georgia Ragia, et al.
Frontiers in Pharmacology (2023) Vol. 14
Open Access | Times Cited: 9
Design, Synthesis, and Evaluation of New Hybrid Derivatives of 5,6-Dihydro-4H-pyrrolo[3,2,1-ij]quinolin-2(1H)-one as Potential Dual Inhibitors of Blood Coagulation Factors Xa and XIa
A. A. Skoptsova, Athina Geronikaki, N. P. Novichikhina, et al.
Molecules (2024) Vol. 29, Iss. 2, pp. 373-373
Open Access | Times Cited: 1
A. A. Skoptsova, Athina Geronikaki, N. P. Novichikhina, et al.
Molecules (2024) Vol. 29, Iss. 2, pp. 373-373
Open Access | Times Cited: 1
Milvexian: evaluating the factor XIa inhibitor for the treatment of acute coronary syndrome
Udaya S. Tantry, Lekshminarayan Raghavakurup, Richard C. Becker, et al.
Expert Opinion on Pharmacotherapy (2024) Vol. 25, Iss. 10, pp. 1271-1280
Closed Access
Udaya S. Tantry, Lekshminarayan Raghavakurup, Richard C. Becker, et al.
Expert Opinion on Pharmacotherapy (2024) Vol. 25, Iss. 10, pp. 1271-1280
Closed Access
Synthesis and anticoagulant activity of methyl 2-{2-[2-(4,4,6-trimethyl-2-oxo-4H-pyrrolo[3,2,1-ij]quinolin-1(2H)-ylidene)hydrazineyl]-4-oxothiazol-5(4H)-ylidene}acetates against blood clotting factors Xa, XIa and thrombin
A. Yu. Potapov, A. A. Skoptsova, N. P. Novichikhina, et al.
Russian Chemical Bulletin (2024) Vol. 73, Iss. 9, pp. 2765-2771
Closed Access
A. Yu. Potapov, A. A. Skoptsova, N. P. Novichikhina, et al.
Russian Chemical Bulletin (2024) Vol. 73, Iss. 9, pp. 2765-2771
Closed Access
Advances in Development of Drug Treatment for Hemophilia with Inhibitors
Surasak Wichaiyo
ACS Pharmacology & Translational Science (2024) Vol. 7, Iss. 12, pp. 3795-3803
Open Access
Surasak Wichaiyo
ACS Pharmacology & Translational Science (2024) Vol. 7, Iss. 12, pp. 3795-3803
Open Access
